Champions Oncology (CSBR) Net Cash Flow Growth (3y) (2013 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 27.97% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -164.05% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 168.48% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 858.59% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 63.95% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 42.13% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 53.91% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -46.25% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 53.91% |
| Apr 30, 2026 | -13.88% |
| Jan 31, 2026 | -54.61% |
| Oct 31, 2025 | -38.44% |
| Jul 31, 2025 | 36.96% |
| Apr 30, 2025 | 178.12% |
| Jan 31, 2025 | -51.47% |
| Oct 31, 2024 | -29.59% |
| Jul 31, 2024 | 33.84% |
| Apr 30, 2024 | 12.29% |
| Jan 31, 2024 | 2.40% |
| Oct 31, 2023 | -26.32% |
| Jul 31, 2023 | -55.39% |
| Apr 30, 2023 | -32.03% |
| Jan 31, 2023 | 18.04% |
| Oct 31, 2022 | 68.17% |
| Jul 31, 2022 | 2.85% |
| Apr 30, 2022 | 83.63% |
| Jan 31, 2022 | 42.52% |
| Oct 31, 2021 | -0.30% |